Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by K. Nan
P1.01-108 Management of Anlotinib-Related Adverse Events: Data From ALTER 0303
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
P1.01-107 the Impact of Anlotinib on Quality of Life in Patients With Advance NSCLC: Post-Hoc Analysis of a Phase III Randomized Control Trial (ALTER0303)
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Related publications
Management of Anesthesia-Related Adverse Events
THE JOURNAL OF JAPAN SOCIETY FOR CLINICAL ANESTHESIA
Management of Immune Checkpoint Inhibitor‐related Dermatologic Adverse Events
Thoracic Cancer
Medicine
Pulmonary
Respiratory Medicine
Oncology
JCSE01.19 ALTER-0303 Study: Tumor Mutation Index (TMI) for Clinical Response to Anlotinib in Advanced NSCLC Patients at 3rd Line
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Cardiovascular Immune‐related Adverse Events: Evaluation, Diagnosis and Management
Asia-Pacific Journal of Clinical Oncology
Medicine
Oncology
P3.13-09 ALTER-0303 Study: Tumor Mutation Index (TMI) for Clinical Response to Anlotinib in Advanced NSCLC Patients at 3rd Line
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
EL25Management of Immune-Related Adverse Events
Annals of Oncology
Medicine
Oncology
Hematology
P1.01-17 Immune-Related Adverse Events in Patients With Metastatic Non-Small Cell Lung Cancer: Sex Differences and Response to Therapy
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Clinical Management of Adverse Events Associated With Lorlatinib
Oncologist
Cancer Research
Medicine
Oncology
Management of Egfr Tki–induced Dermatologic Adverse Events
Current Oncology
Oncology
